| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |